Divergent dietary thresholds for all-cause versus cardiovascular mortality in sarcopenia and advanced cardiovascular-kidney-metabolic syndrome: a national prospective cohort study.

IF 1.9
Yuqi He, Jiantong Sun, Chao Liu, Xiaolong Yang, Weili Fu
{"title":"Divergent dietary thresholds for all-cause versus cardiovascular mortality in sarcopenia and advanced cardiovascular-kidney-metabolic syndrome: a national prospective cohort study.","authors":"Yuqi He, Jiantong Sun, Chao Liu, Xiaolong Yang, Weili Fu","doi":"10.4103/singaporemedj.SMJ-2025-292","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Sarcopenia and cardiovascular-kidney-metabolic (CKM) syndrome are common comorbidities. We evaluated their cumulative impact on all-cause and cardiovascular mortality, and the modifying effect of a Composite Dietary Antioxidant Index (CDAI).</p><p><strong>Methods: </strong>This prospective study used data from the National Health and Nutrition Examination Survey linked to the National Death Index. Sarcopenia (Foundation for the National Institutes of Health criteria) and CKM syndrome (American Heart Association stages, dichotomised into advanced/non-advanced) defined the primary exposure. Outcomes were all-cause and cardiovascular mortality. Cox models estimated hazard ratios (HRs). Maximally selected rank statistics determined optimal outcome-specific CDAI thresholds.</p><p><strong>Results: </strong>Among 8782 participants (median follow-up 131 months), advanced CKM syndrome was associated with sarcopenia (odds ratio 2.29, 95% confidence interval [CI] 1.48-3.53). This study demonstrated a cumulative risk of comorbid advanced CKM syndrome and sarcopenia on mortality, with this group exhibiting the highest risk for all-cause (HR 3.11, 95% CI 1.72-5.61) and cardiovascular (HR 1.80, 95% CI 1.04-3.12) mortality. Furthermore, we identified an inverse relationship between disease burden and protective CDAI thresholds for all-cause mortality, whereas cardiovascular mortality exhibited a distinctly higher threshold. Specifically, the comorbidity group required lower antioxidant intake (CDAI >-3.80) than the non-comorbidity group (CDAI >-1.19) for all-cause mortality. Conversely, cardiovascular mortality required a substantially higher threshold (CDAI >3.04).</p><p><strong>Conclusion: </strong>Coexisting advanced CKM syndrome and sarcopenia present a significant cumulative mortality risk. Exploratory analyses suggest that this risk may be mitigated by dietary antioxidants, but the protective threshold is context-dependent. Modest dietary improvement was associated with improved all-cause survival in high-risk patients, whereas higher antioxidant intake correlated with better cardiovascular outcomes. These results suggest that precision nutrition strategies may vary depending on the specific health outcome.</p>","PeriodicalId":94289,"journal":{"name":"Singapore medical journal","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2026-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Singapore medical journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/singaporemedj.SMJ-2025-292","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Sarcopenia and cardiovascular-kidney-metabolic (CKM) syndrome are common comorbidities. We evaluated their cumulative impact on all-cause and cardiovascular mortality, and the modifying effect of a Composite Dietary Antioxidant Index (CDAI).

Methods: This prospective study used data from the National Health and Nutrition Examination Survey linked to the National Death Index. Sarcopenia (Foundation for the National Institutes of Health criteria) and CKM syndrome (American Heart Association stages, dichotomised into advanced/non-advanced) defined the primary exposure. Outcomes were all-cause and cardiovascular mortality. Cox models estimated hazard ratios (HRs). Maximally selected rank statistics determined optimal outcome-specific CDAI thresholds.

Results: Among 8782 participants (median follow-up 131 months), advanced CKM syndrome was associated with sarcopenia (odds ratio 2.29, 95% confidence interval [CI] 1.48-3.53). This study demonstrated a cumulative risk of comorbid advanced CKM syndrome and sarcopenia on mortality, with this group exhibiting the highest risk for all-cause (HR 3.11, 95% CI 1.72-5.61) and cardiovascular (HR 1.80, 95% CI 1.04-3.12) mortality. Furthermore, we identified an inverse relationship between disease burden and protective CDAI thresholds for all-cause mortality, whereas cardiovascular mortality exhibited a distinctly higher threshold. Specifically, the comorbidity group required lower antioxidant intake (CDAI >-3.80) than the non-comorbidity group (CDAI >-1.19) for all-cause mortality. Conversely, cardiovascular mortality required a substantially higher threshold (CDAI >3.04).

Conclusion: Coexisting advanced CKM syndrome and sarcopenia present a significant cumulative mortality risk. Exploratory analyses suggest that this risk may be mitigated by dietary antioxidants, but the protective threshold is context-dependent. Modest dietary improvement was associated with improved all-cause survival in high-risk patients, whereas higher antioxidant intake correlated with better cardiovascular outcomes. These results suggest that precision nutrition strategies may vary depending on the specific health outcome.

在肌肉减少症和晚期心血管-肾脏代谢综合征中,不同的饮食阈值对全因死亡率和心血管死亡率的影响:一项全国前瞻性队列研究
前言:肌少症和心肾代谢综合征是常见的合并症。我们评估了它们对全因死亡率和心血管死亡率的累积影响,以及复合膳食抗氧化指数(CDAI)的调节作用。方法:这项前瞻性研究使用了与国家死亡指数相关的国家健康和营养检查调查的数据。骨骼肌减少症(美国国立卫生研究院基金会标准)和CKM综合征(美国心脏协会分期,分为晚期/非晚期)定义了主要暴露。结果是全因死亡率和心血管死亡率。Cox模型估计了风险比(hr)。最大选择的秩统计确定了特定结果的最佳CDAI阈值。结果:在8782名参与者中(中位随访131个月),晚期CKM综合征与肌肉减少症相关(优势比2.29,95%可信区间[CI] 1.48-3.53)。该研究表明,合并晚期CKM综合征和肌肉减少症对死亡率的累积风险,该组显示出全因死亡率(HR 3.11, 95% CI 1.72-5.61)和心血管死亡率(HR 1.80, 95% CI 1.04-3.12)的最高风险。此外,我们发现疾病负担与全因死亡率的保护性CDAI阈值之间存在反比关系,而心血管死亡率的阈值明显更高。具体而言,与非共病组(CDAI >-1.19)相比,共病组的全因死亡率需要更低的抗氧化剂摄入量(CDAI >-3.80)。相反,心血管死亡率需要高得多的阈值(CDAI bb0 3.04)。结论:并发的晚期CKM综合征和肌肉减少症存在显著的累积死亡风险。探索性分析表明,这种风险可以通过饮食抗氧化剂减轻,但保护阈值取决于环境。适度的饮食改善与高危患者全因生存率的提高有关,而较高的抗氧化剂摄入与更好的心血管预后相关。这些结果表明,精确的营养策略可能因具体的健康结果而异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书